Evidence Synthesis
Standard Shift Narrative for SMSPHARMA on 2026-09-18 The Indian equity market experienced a standard shift for SMSPHARMA, driven by accelerating trends in various key metrics.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 18 Sept 2026, 04:37
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Standard Shift Narrative for SMSPHARMA on 2026-09-18 The Indian equity market experienced a standard shift for SMSPHARMA, driven by accelerating trends in various key metrics.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 34.65 % | 14.96 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 14.96 % | 11.41 | ▲ |
| REVENUE_GROWTH_YOY | 5.6 % | -3.5 | ▲ |
| PRICE_CHANGE_PERCENT | 2.68 % | — | - |
| DAILY_VOLUME | 6,71,338 shares | 6,51,198 | ▲ |
| CLOSE_PRICE | 413.75 INR | 402.95 | ▲ |